Evolution of angiotensin II-mediated atherosclerosis in ApoE KO mice

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 565-570

  Cha, John ^a   Ivanov, Vadim ^a   Ivanova, Svetlana ^a   Kalinovsky, Tatiana ^a   Rath, Matthias ^a   Niedzwiecki, Aleksandra ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Angiotensin II; Aortic dissection; ApoE KO mice; Atherosclerosis

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH ANOMALY; AORTA DISSECTION; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP;

MUS;

EID: 77956696818     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000298     Document Type: Article

References (24)

1. Schwartz SM, Galis ZS, Rosenfeld ME and Falk E: Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 27: 705-713, 2007.
2. Rath M: Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency, leading to the deposition of lipoprotein(a) and fibrinogen/fibrin in the vascular wall. J Ortho Med 6: 125-134, 1991.
3. Zadelaar S, Kleemann R, Verschuren L, De Vries-van der Weij J, van der Hoorn J, Princen HM and Kooistra T: Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 27: 1706-1721, 2007.
4. Kleemann R, Zadelaar S and Kooistra T: Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79: 360-376, 2008.
5. Whitman SC: A practical approach using mice in atherosclerosis research. Clin Biochem Rev 25: 81-93, 2004.
6. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa Y, Fazio S and Kon V: Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Atherosclerosis 184: 312-321, 2006.
7. Reddick RL, Zhang SH and Maeda N: Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression. Atheroscler Thromb 14: 141-147, 1994.
8. Kanters E, Pasparakis M, Gijbels MJJ, et al: Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J Clin Invest 112: 1176-1185, 2003.
9. Kanters E, Gijbels MJJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH and de Winther MPJ: Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood 103: 934-940, 2004.
10. Paravicini TM and Touyz RM: NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31: S170-S180, 2008.
11. Gavazzi G, Deffert C, Trocme C, Schäppi M, Herrmann FR and Heinz Krause K: NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 50: 189-196, 2007.
12. Fernandez ML and Volek JS: Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. Nutr Metab 3: 17, 2006.
13. Maeda N, Hagihara H, Nakata Y, Hiller S, Wilder J and Reddick R: Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci USA 97: 841-846, 2000.
14. Liu X, Wu H, Byrne M, Krane S and Jaenisch R: Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA 94: 1852-1856, 1997.
15. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN and Sueishi K: Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 27: 1159-1165, 2007.
16. Sautin YY and Johnson RJ: Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27: 608-619, 2008.
17. Fay WP, Garg N and Sunkar M: Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 27: 1231-1237, 2007.
18. Yano Y, Shimokawa K, Okada Y and Noma A: Immunolocalization of lipoprotein(a) in wounded tissues. J Histochern Cytochem 45: 559-568, 1997.
19. Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr and Simari RD: Lipoprotein(a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 98: 2980-2987, 2001.
20. Lou X, Boonmark NW, Horrigan FT, Degen JL and Lawn RM: Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice. PNAS 95: 12591-12595, 1998.
21. Fattori R, Bacchi-Reggiani L, Bertaccini P, Napoli G, Fusco F, Longo M, Pierangeli A and Gavelli G: Evolution of aortic dissection after surgical repair. Am J Cardiol 86: 868-872, 2000.
22. Tsai T, Fattori R, Trimarchi S, et al: Long-term survival in patients presenting with type b acute aortic dissection: insights from the international registry of acute aortic dissection. Circulation 114: 2226-2231, 2006. (Pubitemid 44789497)
23. Saraff K, Babamusta F, Cassis LA and Daugherty A: Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626, 2003.
24. Lind SE, McDonagh JR and Smith CJ: Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood 82: 1522-1531, 1993.